Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Boehringer-Ingelheim
Company Monitoring Page for Boehringer-Ingelheim
latest headlines for company on cafepharma
Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year
Endpoints
Wed, 01/4/23 - 05:16 pm
Tags:
Sanofi
,
Boehringer Ingelheim
,
Zantac
,
legal
Boehringer Ingelheim deepens its collaboration with Click Therapeutics in a deal worth $460M
Endpoints
Mon, 12/19/22 - 10:07 pm
Tags:
Boehringer Ingelheim
,
Click Therapeutics
,
digital therapeutics
,
schizophrenia
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Wed, 12/7/22 - 11:40 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
type 2 diabetes
,
Jardiance
,
pediatri
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
chronic kideny disease
,
Jardiance
,
Farxiga
,
AstraZeneca
Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3
Pharmaphorum
Thu, 10/27/22 - 10:41 am
Tags:
Boehringer Ingelheim
,
BI 1015550
,
IPH
Boehringer and Surrozen Seek Retinal Therapies Along the Wnt Pathway
BioSpace
Fri, 10/7/22 - 10:39 am
Tags:
Boehringer Ingelheim
,
Surrozen
,
Wnt pathway
,
retinal diseases
,
R&D
Boehringer Ingelheim preps FDA submission with new data in rare pediatric lung disease
Endpoints
Tue, 09/6/22 - 05:00 pm
Tags:
Boehringer Ingelheim
,
nintedanib
,
Ofev
Boehringer reports Phase III data for nintedanib in interstitial lung disease
Clinical Trials Arena
Tue, 09/6/22 - 10:45 am
Tags:
Boehringer Ingelheim
,
clinical trials
,
nintedanib
,
interstitial lung disease
Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod
Fierce Pharma
Fri, 09/2/22 - 12:19 pm
Tags:
Boehringer Ingelheim
,
FDA
,
dermatology
,
GPP
,
Spevigo
In damage control mode, Perrigo clarifies that it's off the hook in key Zantac case
Fierce Pharma
Thu, 08/18/22 - 11:18 pm
Tags:
Perrigo
,
Boehringer Ingelheim
,
GSK
,
legal
,
Zantac
Boehringer takes on antimicrobial resistance with Evotec, bioMérieux JV
Pharmaforum
Wed, 07/6/22 - 11:00 am
Tags:
Boehringer Ingelheim
,
Evotec
,
Biomerieux
,
antimicrobial resistance
,
antibiotic resistance
,
Aurobac Therapeutics
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
Tue, 07/5/22 - 11:52 pm
Tags:
China
,
biotech
,
WuXi Biologics
,
Boehringer Ingelheim
,
Siemens Healthineers
,
AstraZeneca
Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers
BioSpace
Tue, 06/28/22 - 10:40 am
Tags:
Boehringer Ingelheim
,
BiomX
,
biomarkers
,
microbiome
,
IBD
Boehringer Ingelheim to incubate biotechs with Hong Kong R&D leader
Endpoints
Fri, 06/17/22 - 09:51 am
Tags:
Boehringer Ingelheim
,
R&D
,
Hong Kong
,
incubators
Boehringer Ingelheim Signs Option to Acquire Immunology Partner, Trutino Biosciences
BioSpace
Wed, 06/15/22 - 10:56 am
Tags:
Boehringer Ingelheim
,
Trutino Biosciences
,
M&A
,
cancer
ASCO 2022 – the spirit of Rova-T struggles to live on
EP Vantage
Tue, 06/7/22 - 10:19 am
Tags:
ASCO 2022
,
Rova-T
,
AbbVie
,
Harpoon Therapeutics
,
Amgen
,
Boehringer Ingelheim
Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org
Endpoints
Fri, 06/3/22 - 10:54 am
Tags:
Boehringer Ingelheim
,
oncology
,
cancer
,
Singapore
,
R&D
Boehringer OKs $100M biobucks deal for hearing loss R&D project
Fierce Biotech
Wed, 04/13/22 - 10:38 am
Tags:
Boehringer Ingelheim
,
hearing loss
,
Autigen
,
biobucks
Boehringer Ingelheim boosts R&D commitment, promises up to 15 new product launches by 2025
Endpoints
Tue, 04/5/22 - 11:31 pm
Tags:
Boehringer Ingelheim
,
R&D
Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results
BioSpace
Wed, 03/16/22 - 11:20 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
clinical trials
,
chronic kidney disease
,
empagliflozin
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.